Your browser doesn't support javascript.
loading
Cost-effectiveness analysis of five drugs for treating postmenopausal women in the United States with osteoporosis and a very high fracture risk.
Luo, C; Qin, S-X; Wang, Q-Y; Li, Y-F; Qu, X-L; Yue, C; Hu, L; Sheng, Z-F; Wang, X-B; Wan, X-M.
Afiliação
  • Luo C; Hunan Provincial Key Laboratory of Metabolic Bone Diseases, Department of Metabolism and Endocrinology, Health Management Center, National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital of Central South University, 139 Renmin Middle Road, Changsha, 410011, Hunan, People
  • Qin SX; Department of Pharmacy, The Second Xiangya Hospital, Central South University, 139 Renmin Middle Road, Changsha, 410011, Hunan, People's Republic of China.
  • Wang QY; Hunan Provincial Key Laboratory of Metabolic Bone Diseases, Department of Metabolism and Endocrinology, Health Management Center, National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital of Central South University, 139 Renmin Middle Road, Changsha, 410011, Hunan, People
  • Li YF; Hunan Provincial Key Laboratory of Metabolic Bone Diseases, Department of Metabolism and Endocrinology, Health Management Center, National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital of Central South University, 139 Renmin Middle Road, Changsha, 410011, Hunan, People
  • Qu XL; Hunan Provincial Key Laboratory of Metabolic Bone Diseases, Department of Metabolism and Endocrinology, Health Management Center, National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital of Central South University, 139 Renmin Middle Road, Changsha, 410011, Hunan, People
  • Yue C; Hunan Provincial Key Laboratory of Metabolic Bone Diseases, Department of Metabolism and Endocrinology, Health Management Center, National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital of Central South University, 139 Renmin Middle Road, Changsha, 410011, Hunan, People
  • Hu L; Hunan Provincial Key Laboratory of Metabolic Bone Diseases, Department of Metabolism and Endocrinology, Health Management Center, National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital of Central South University, 139 Renmin Middle Road, Changsha, 410011, Hunan, People
  • Sheng ZF; Hunan Provincial Key Laboratory of Metabolic Bone Diseases, Department of Metabolism and Endocrinology, Health Management Center, National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital of Central South University, 139 Renmin Middle Road, Changsha, 410011, Hunan, People
  • Wang XB; Divisions of Endocrinology, Metabolism, and Nutrition, Departments of Medicine and Surgery, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
  • Wan XM; Department of Pharmacy, The Second Xiangya Hospital, Central South University, 139 Renmin Middle Road, Changsha, 410011, Hunan, People's Republic of China. wanxiaomin@csu.edu.cn.
J Endocrinol Invest ; 46(2): 367-379, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36044169

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose / Osteoporose Pós-Menopausa / Conservadores da Densidade Óssea / Fraturas do Quadril Tipo de estudo: Etiology_studies / Guideline / Health_economic_evaluation / Risk_factors_studies Limite: Female / Humans País/Região como assunto: America do norte Idioma: En Revista: J Endocrinol Invest Ano de publicação: 2023 Tipo de documento: Article País de publicação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose / Osteoporose Pós-Menopausa / Conservadores da Densidade Óssea / Fraturas do Quadril Tipo de estudo: Etiology_studies / Guideline / Health_economic_evaluation / Risk_factors_studies Limite: Female / Humans País/Região como assunto: America do norte Idioma: En Revista: J Endocrinol Invest Ano de publicação: 2023 Tipo de documento: Article País de publicação: Itália